Abstract
PKCd, a member of the novel PKC family, has been widely implicated as mediator of apoptosis in response to phorbol esters and chemotherapeutic agents, and it is differentially expressed in various human cancer types. A characteristic of PKCd is that it is regulated by tyrosine phosphorylation, and in some cases this post-translational modification seems to be essential for the response to stimuli. PKCd may be an attractive target for cancer therapeutics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acs, P., Beheshti, M., Szállási, Z., Li, L, Yuspa, S.H., & Blumberg, P. M. (2000). Effect of a tyrosine 155 to phenylalanine mutation of protein kinase cdelta on the proliferative and tumorigenic properties of NIH 3T3 fibroblasts. Carcinogenesis, 21, 887–891.
Afrasiabi, E., Ahlgren, J., Bergelin, N., & Törnquist K. (2008). Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: Evidence for an effect mediated by PKCdelta. Molecular and Cellular Endocrinology, 292, 26–35.
Alonso-Escolano, D., Medina, C., Cieslik, K., Radomski, A., Jurasz, P., Santos-Martínez, M. J., et al. (2006). Protein kinase C delta mediates platelet-induced breast cancer cell invasion. The Journal of Pharmacology and Experimental Therapeutics, 318, 373–380.
Alvaro, V., Lévy, L., Dubray, C., Roche, A., Peillon, F., Quérat, B., et al. (1993). Invasive human pituitary tumors express a pointmutated alpha-protein kinase-C. The Journal of Clinical Endocrinology and Metabolism, 77, 1125–1129.
Ashton, A. W., Watanabe, G., Albanese, C., Harrington, E. O., Ware, J. A., & Pestell, R. G. (1999). Protein kinase Cdelta inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27(Kip1). The Journal of Biological Chemistry, 274, 20805–20811.
Basu, A., Adkins, B., & Basu, C. (2008). Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway. Cancer Research, 68, 2795–2802.
Basu, A., Contreras, A. G. Datta, D., Flynn, E., Zeng, L., Cohen, H. T., et al. (2008). Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Research, 68, 5689–5698.
Basu, A., Mohanty, S., & Sun, B. (2001). Differential sensitivity of breast cancer cells to tumor necrosis factor-alpha: Involvement of protein kinase C. Biochemical and Biophysical Research Communications, 280, 883–891.
Basu, A., & Tu, H. (2005). Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta. Biochemical and Biophysical Research Communications, 334, 1068–1073.
Basu, A., Weixel, K., & Saijo, N. (1996). Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells. Cell Growth and Differentiation, 7, 1507–1512.
Bharti, A., Kraeft, S. K., Gounder, M., Pandey, P., Jin, S., Yuan, Z.M., et al. (1998). Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: Implications for apoptosis. Molecular and Cellular Biology, 18, 6719–6728.
Blass, M., Kronfeld, I., Kazimirsky, G., Blumberg, P. M., & Brodie, C. (2002). Tyrosine phosphorylation of protein kinase Cdelta is essential for its apoptotic effect in response to etoposide. Molecular and Cellular Biology, 22, 182–195.
Brenner, W., Greber, I., Gudejko-Thiel, J., Beitz, S., Schneider, E., Walenta, S., et al. (2008). Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase. International Journal of Oncology, 32, 1125–1131.
Brodie, C., & Blumberg, P. M. (2003). Regulation of cell apoptosis by protein kinase c delta. Apoptosis, 8, 19–27.
Brodie, C., Bogi, K., Acs, P., Lorenzo, P. S., Baskin, L., & Blumberg, P. M. (1998). Protein kinase C delta (PKCdelta) inhibits the expression of glutamine synthetase in glial cells via the PKCdelta regulatory domain and its tyrosine phosphorylation. The Journal of Biological Chemistry, 273, 30713–30718.
Budas, G. R., Churchill, E. N., & Mochly-Rosen, D. (2007). Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury. Pharmacological Research, 55, 523–536.
Cai, J., Donaldson, A., Yang, M., German, M. S., Enikolopov, G., & Iacovitti, L. (2008). The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson’s disease model. Stem Cells, 27, 220–229.
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982). Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. The Journal of Biological Chemistry, 257, 7847–7851.
Cerda, S. R., Mustafi, R., Little, H., Cohen, G., Khare, S., Moore, C., et al. (2006). Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators. Oncogene, 25, 3123–3138.
Chang, J. T., Lu, Y. C., Chen, Y. J., Tseng, C. P., Chen, Y. L., Fang, C. W., et al. (2006). hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells. British Journal of Cancer, 94, 870–878.
Craven, P. A., & DeRubertis, F. R. (1994). Loss of protein kinase C delta isozyme immunoreactivity in human adenocarcinomas. Digestive Diseases and Sciences, 39, 481–489.
Cross, T., Griffiths, G., Deacon, E., Sallis, R., Gough, M., Watters, D., et al. (2000). PKC-delta is an apoptotic lamin kinase. Oncogene, 19, 2331–2337.
da Rocha, A. B., Mans, D. R., Regner, A., & Schwartsmann, G. (2002). Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas? The Oncologist, 7, 17–33.
Datta, R., Banach, D., Kojima, H., Talanian, R. V., Alnemri, E. S., Wong, W. W., et al. (1996). Activation of the CPP32 protease in apoptosis induced by 1-beta- d -arabinofuranosylcytosine and other DNA-damaging agents. Blood, 88, 1936–1943.
Dempsey, E. C., Newton, A. C., Mochly-Rosen, D., Fields, A. P., Reyland, M. E., Insel, P. A., et al. (2000). Protein kinase C isozymes and the regulation of diverse cell responses. American Journal of Physiology. Lung Cellular and Molecular Physiology, 279, L429–L438.
Deng, X., Hofmann, E. R., Villanueva, A., Hobert, O., Capodieci, P., Veach, D. R., et al. (2004). Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation. Nature Genetics, 36, 906–912.
Denning, M. F., Dlugosz, A. A., Howett, M. K., & Yuspa, S. H. (1993). Expression of an oncogenic rasHa gene in murine keratinocytes induces tyrosine phosphorylation and reduced activity of protein kinase C delta. The Journal of Biological Chemistry, 268, 26079–26081.
Denning, M. F., Wang, Y., Nickoloff, B. J., & Wrone-Smith, T. (1998). Protein kinase Cdelta is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. The Journal of Biological Chemistry, 273, 29995–30002.
Denning, M. F., Wang, Y., Tibudan, S., Alkan, S., Nickoloff, B. J., & Qin, J. Z. (2002). Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death and Differentiation, 9, 40–52.
DeVries-Seimon, T. A., Ohm, A. M., Humphries, M. J., & Reyland M. E. (2007). Induction of apoptosis is driven by nuclear retention of protein kinase C delta. The Journal of Biological Chemistry, 282, 22307–22314.
Durgan, J., Michael, N., Totty, N., & Parker, P. J. (2007). Novel phosphorylation sites of protein kinase C delta activation. FEBS Letters, 581, 3377–3381.
El-Rayes, B. F., Ali, S., Philip, P. A., & Sarkar, F. H. (2008). Protein kinase C: A target for therapy in pancreatic cancer. Pancreas, 36, 346–352.
Emoto, Y., Kisaki, H., Manome, Y., Kharbanda, S., & Kufe, D. (1996). Activation of protein kinase Cdelta in human myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine. Blood, 87, 1990–1996.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., et al. (1995). Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO Journal, 14, 6148–6156.
Fields, A. P., Frederick, L. A., & Regala, R. P. (2007). Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer. Biochemical Society Transactions, 35, 996–1000.
Fukumoto, S., Nishizawa, Y., Hosoi, M., Koyama, H., Yamakawa, K., Ohno, S., et al. (1997). Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. The Journal of Biological Chemistry, 272, 13816–13822.
García-Fernández, L. F., Losada, A., Alcaide, V., Alvarez, A. M., Cuadrado, A., et al. (2002). Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C delta. Oncogene, 21, 7533–7544.
Gewirtz, D. A. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochemical Pharmacology, 57, 727–741.
Ghayur, T., Hugunin, M., Talanian, R. V., Ratnofsky, S., Quinlan, C., Emoto, Y., et al. (1996). Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. The Journal of Experimental Medicine, 184, 2399–2404.
Gliki, G., Wheeler-Jones, C., & Zachary, I. (2002). Vascular endothelial growth factor induces protein kinase C (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3´-kinasemediates PKC delta phosphorylation: Role of PKC in angiogenesis. Cell Biology International, 26, 751–759.
Godbout, J. P., Pesavento, J., Hartman, M. E., Manson, S. R., & Freund, G. G. (2002). Methylglyoxal enhances cisplatininduced cytotoxicity by activating protein kinase Cdelta. The Journal of Biological Chemistry,277, 2554–2561.
Gomel, R., Xiang, C., Finniss, S., Lee, H. K., Lu, W., Okhrimenko, H., et al. (2007). The localization of protein kinase Cdelta in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways. Molecular Cancer Research, 5, 627–639.
Gonzalez-Guerrico, A. M., & Kazanietz, M. G. (2005). Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: A key role for protein kinase C delta. The Journal of Biological Chemistry, 280, 38982–38991.
Griner, E., & Kazanietz, M. G. (2007). Protein kinase C and other effectors in cancer. Nature Reviews. Cancer, 7, 281–294.
Gschwendt, M. (1995). Protein kinase C delta. European Journal of Biochemistry, 259, 555–564.
Gschwendt, M., Müller, H. J., Kielbassa, K., Zang, R., Kittstein, W., Rincke, G., et al. (1994). Rottlerin, a novel protein kinase inhibitor. Biochemical and Biophysical Research Communications, 199, 93–98.
He, Y., Liu, J., Durrant, D., Yang, H. S., Sweatman, T., Lothstein, L., et al. (2005). N-benzyladriamycin-14-valerate (AD198) induces apoptosis through protein kinase C-delta-induced phosphorylation of phospholipid scramblase 3. Cancer Research, 65, 10016–10023.
Humphries, M. J., Limesand, K. H., Schneider, J. C., Nakayama, K. I., Anderson, S. M., Reyland, M. E. (2006). Suppression of apoptosis in the protein kinase C delta null mice. The Journal of Biological Chemistry, 281, 9728–9737.
Hung, J. H., Lu, Y. S., Wang, Y. C., Ma, Y. H., Wang, D. S., Kulp, S. K., et al. (2008). FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Cancer Research, 68, 1204–1212.
Huppi, K., Siwarski, D., Goodnight, J., & Mischak, H. (1994). Assignment of the protein kinase C delta polypeptide gene (PRKCD) to human chromosome 3 and mouse chromosome 14. Genomics, 19, 161–162.
Hussaini, I. M., Trotter, C., Zhao, Y., Abdel-Fattah, R., Amos, S., Xiao, A., Agi, C. U., et al. (2007). Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. American Journal of Pathology, 170, 356-365.
Iioka, Y., Mishima, K., Azuma, N., Tsuchida, A., Takagi, Y., Aoki, T., et al. (2005). Overexpression of protein kinase Cdelta enhances cisplatin-induced cytotoxicity correlated with p53 in gastric cancer cell line. Pathobiology, 72, 152–159.
Iwabu, A., Smith, K., Allen, F. D., Lauffenburger, D. A., & Wells, A. (2004). Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. The Journal of Biological Chemistry, 279, 14551–14560.
Jackson, D. N., & Foster, D. A. (2004). The enigmatic protein kinase Cdelta: Complex roles in cell proliferation and survival. FASEB Journal, 18, 627–636.
Joseloff, E., Cataisson, C., Aamodt, H., Ocheni, H., Blumberg, P., Kraker, A. J., et al. (2002). Src family kinases phosphorylate protein kinase C delta on tyrosine residues and modify the neoplastic phenotype of skin keratinocytes. The Journal of Biological Chemistry, 277, 12318–12323.
Jun, C. D., Oh, C. D., Kwak, H. J., Pae, H. O., Yoo, J. C., Choi, B. M., et al. (1999). Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: Involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. Journal of Immunology, 162, 3395–3401.
Kajimoto, T., Ohmori, S., Shirai, Y., Sakai, N., & Saito, N. (2001). Subtype-specific translocation of the delta subtype of protein kinase C and its activation by tyrosine phosphorylation induced by ceramide in HeLa cells. Molecular and Cellular Biology, 21, 1769–1783.
Kaul, S., Anantharam, V., Yang, Y., Choi, C. J., Kanthasamy, A., & Kanthasamy, A. G. (2005). Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. The Journal of Biological Chemistry, 280, 28721–28730.
Kaur, S., Parmar, S., Smith, J., Katsoulidis, E., Li, Y., Sassano, A., et al. (2005). Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells. Experimental Hematology, 33, 550–557.
Kelley, S. K., & Ashkenazi, A. (2004). Targeting death receptors in cancer with Apo2L/TRAIL. Current Opinion in Pharmacology, 4, 333–339.
Keshamouni, V. G., Mattingly, R. R., & Reddy, K. B. (2002). Mechanism of 17-beta-estradiolinduced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta. The Journal of Biological Chemistry, 277, 22558–22565.
Khwaja, A., & Tatton, L. (1999). Caspase-mediated proteolysis and activation of protein kinase Cdelta plays a central role in neutrophil apoptosis. Blood, 94, 291–301.
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., & Nishizuka, Y. (1983). Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. The Journal of Biological Chemistry, 258, 11442–11445.
Kiley, S. C., Clark, K. J., Duddy, S. K., Welch, D. R., & Jaken, S. (1999). Increased protein kinase C delta in mammary tumor cells: Relationship to transformtion and metastatic progression. Oncogene, 18, 6748–6757.
Kiley, S. C., Clark, K. J., Goodnough, M., Welch, D. R., Jaken, S. (1999). Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Research, 59, 3230–3238.
Kilpatrick, L. E., Lee, J. Y., Haines, K. M., Campbell, D. E., Sullivan, K. E., & Korchak, H. M. (2002). A role for PKC-delta and PI 3-kinase in TNF-alpha-mediated antiapoptotic signaling in the human neutrophil. American Journal of Physiology. Cell Physiology, 283, C48–C57.
Kim, Y., Lee, Y. S., Choe, J., Lee, H., Kim, Y. M., & Jeoung, D. (2008). CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signalling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2. The Journal of Biological Chemistry, 283, 22513–22528.
Kim, E. H., Lee, H. J., Lee, D. H., Bae, S., Soh, J. W., Jeoung, D., et al. (2007). Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide. Cancer Research,67, 6333–6341.
Kim, Y. H., Lim, J. H., Lee, T. J., Park, J. W., & Kwon, T. K. (2007). Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway. Journal of Cellular Biochemistry, 101, 987–995.
Koike, K., Fujii, T., Nakamura, A. M., Yokoyama, G., Yamana, H., Kuwano, M., et al. (2006). Activation of protein kinase C delta induces growth arrest in NPA thyroid cancer cells through extracellular signal-regulated kinase mitogen-activated protein kinase. Thyroid, 16, 333–341.
Koivunen, J., Aaltonen, V., & Peltonen, J. (2006). Protein kinase C (PKC) family in cancer progression. Cancer Letters, 235, 1–10.
Konishi, H., Yamauchi, E., Taniguchi, H., Yamamoto, T., Matsuzaki, H., Takemura, Y., et al. (2001). Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proceedings of the National Academy of Sciences of the United States of America, 98, 6587–6592.
Koren, R., Langzam, L., Paz, A., Livne, P. M., Gal, R., & Sampson, S.R. (2000). Protein kinase C (PKC) isoenzymes immunohistochemistry in lymph node revealing solution-fixed, paraffin-embedded bladder tumors. Applied Immunohistochemistry & Molecular Morphology, 8, 166–171.
Koriyama, H., Kouchi, Z., Umeda, T., Saido, T. C., Momoi, T., Ishiura, S., et al. (1999). Proteolytic activation of protein kinase C delta and epsilon by caspase-3 in U937 cells during chemotherapeutic agent-induced apoptosis. Cellular Signalling, 11, 831–838.
Kronfeld, I., Kazimirsky, G., Lorenzo, P. S., Garfield, S. H., Blumberg, P. M., & Brodie, C. (2000). Phosphorylation of protein kinase Cdelta on distinct tyrosine residues regulates specific cellular functions. The Journal of Biological Chemistry, 275, 35491–35498.
Kruger, J. S., & Reddy, K. B. (2003). Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Molecular Cancer Research, 1, 801–809.
Langzam, L., Koren, R., Gal, R., Kugel, V., Paz, A., Farkas, A., et al. (2001). Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. American Journal of Clinical Pathology, 116, 377–385.
Leach, K. L., James, M. L., & Blumberg, P. M. (1983). Characterization of a specific phorbol ester aporeceptor in mouse brain cytosol. Proceedings of the National Academy of Sciences of the United States of America, 80, 4208–4212.
Lee, J. W., Park, J. A., Kim, S. H., Seo, J. H., Lim, K. J., Jeong, J. W., et al. (2007). Protein kinase C-delta regulates the stability of hypoxia-inducible factor-1 alpha under hypoxia. Cancer Science, 98, 1476–1481.
Lee, Y. J., Soh, J. W., Dean, N. M., Cho, C. K., Kim, T. H., Lee, S. J., et al. (2002). Protein kinase Cdelta overexpression enhances radiation sensitivity via extracellular regulated protein kinase 1/2 activation, abolishing the radiation-induced G(2)-M arrest. Cell Growth and Differentiation, 13, 237–246.
Leitges, M., Mayr, M., Braun, U., Mayr, U., Li, C., Pfister, G., et al. (2001). Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice. The Journal of Clinical Investigation, 108, 1505–1512.
Li, W., Chen, X. H., Kelley, C. A., Alimandi, M., Zhang, J., Chen, Q., et al. (1996). Identification of tyrosine 187 as a protein kinase C-delta phosphorylation site. The Journal of Biological Chemistry, 271, 26404–26409.
Li, W., Jiang, Y. X., Zhang, J., Soon, L., Flechner, L., Kapoor, V., et al. (1998). Protein kinase C-delta is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation. Molecular and Cellular Biology, 18, 5888–5898.
Li, L., Lorenzo, P. S., Bogi, K., Blumberg, P. M., & Yuspa, S. H. (1999). Protein kinase Cdelta targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector. Molecular and Cellular Biology, 19, 8547–8558.
Li, J., Vesey, D. A., Johnson, D. W., & Gobe, G. (2007). Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. Cancer Biology & Therapy, 6, 1944–1950.
Li, C., Wernig, F., Leitges, M., Hu, Y., & Xu, Q. (2003). Mechanical stress-activated PKCdelta regulates smooth muscle cell migration. FASEB Journal, 17, 2106–2108.
Li, S.Y., Yu, B., An, P., Liang, Z. J., Yuan, S. J., & Cai, H. Y. (2004). Effects of cell membrane phospholipid level and protein kinase C isoenzyme expression on hepatic metastasis of colorectal carcinoma. Hepatobiliary & Pancreatic Diseases International, 3, 411–416.
Liu, J., Chen, J., Dai, Q., & Lee, R. M. (2003). Phospholipid scramblase 3 is the mitochondrial target of protein kinase C delta-induced apoptosis. Cancer Research, 63, 1153–1156.
Liu, Z., Liu, X., Nakayama, K. I., Nakayama, K., & Ye, K. (2007). Protein kinase C-delta phosphorylates Ebp1 and prevents its proteolytic degradation, enhancing cell survival. Journal of Neurochemistry, 100, 1278–1288.
Liu, H., Lu, Z. G., Miki, Y., & Yoshida, K. (2007). Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage. Molecular and Cellular Biology, 27, 8480–8491.
Lomonaco, S. L., Kahana, S., Blass, M., Brody, Y., Okhrimenko, H., Xiang, C., et al. (2008). Phosphorylation of protein kinase Cdelta on distinct tyrosine residues induces sustained activation of Erk1/2 via down-regulation of MKP-1: Role in the apoptotic effect of etoposide. The Journal of Biological Chemistry, 283, 17731–17739.
Lorenzo, P. S., & Dennis, P. A. (2003). Modulating protein kinase C (PKC) to increase the efficacy of chemotherapy: Stepping into darkness. Drug Resistance Updates, 6, 329–339.
Lu,W., Finnis, S., Xiang, C., Lee, H. K., Markowitz, Y., Okhrimenko, H., et al. (2007). Tyrosine 311 is phosphorylated by c-Abl and promotes the apoptotic effect of PKCdelta in glioma cells. Biochemical and Biophysical Research Communications, 352, 431–436.
Lu, Z., Hornia, A., Jiang, Y. W., Zang, Q., Ohno, S., & Foster, D. A. (1997). Tumor promotion by depleting cells of protein kinase C delta. Molecular and Cellular Biology, 17, 3418–3428.
Lu, W., Lee, H. K., Xiang, C., Finniss, S., & Brodie, C. (2007). The phosphorylation of tyrosine 332 is necessary for the caspase 3-dependent cleavage of PKCdelta and the regulation of cell apoptosis. Cellular Signalling, 19, 2165–2173.
Mackay, H. J., & Twelves, C. J. (2007). Targeting the protein kinase C family: Are we there yet? Nature Reviews. Cancer, 7, 554–562.
Mandil, R., Ashkenazi, E., Blass, M., Kronfeld, I., Kazimirsky, G., Rosenthal, G., et al. (2001). Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Research,61, 4612–4619.
Martiny-Baron, G., & Fabbro, D. (2007). Classical PKC isoforms in cancer. Pharmacological Research, 55, 477–486.
Mellor, H., & Parker, P. J. (1998). The extended protein kinase C superfamily. Biochemical Journal, 332 (Pt 2), 281–292.
Meresse, P., Dechaux, E., Monneret, C., & Bertounesque, E. (2004). Etoposide: Discovery and medicinal chemistry. Current Medicinal Chemistry, 11, 2443–2466.
Mhaidat, N. M., Thorne, R. F., Zhang, X. D., & Hersey, P. (2007). Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C. Molecular Cancer Research, 5, 1073–1081.
Mischak, H., Goodnight, J. A., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., et al. (1993). Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. The Journal of Biological Chemistry, 268, 6090–6096.
Miyamoto, A., Nakayama, K., Imaki, H., Hirose, S., Jiang, Y., Abe, M., et al. (2002). Increased proliferation of B cells and autoimmunity in mice lacking protein kinase Cdelta. Nature, 416, 865–869.
Muller, I., Niethammer, D., & Bruchelt, G. (1998). Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (Review). International Journal of Molecular Medicine, 1, 491–494.
Nabha, S. M., Glaros, S., Hong, M., Lykkesfeldt, A. E., Schiff, R., Osborne, K., et al. (2005). Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells. Oncogene, 24, 3166–3176.
Nakagawa, M., Oliva, J. L., Kothapalli, D., Fournier, A., Assoian, R. K, & Kazanietz, M. G. (2005). Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. The Journal of Biological Chemistry, 280, 33926–33934.
Nakamura, S., & Nishizuka, Y. (1994). Lipid mediators and protein kinase C activation for the intracellular signaling network. Journal of Biochemistry, 115, 1029–1034.
Ndebele, K., Gona, P., Jin, T. G., Benhaga, N., Chalah, A., Degli-Esposti, M., et al. (2008). Tumor necrosis factor (TNF)-related apoptosisinducing ligand (TRAIL) induced mitochondrial pathway to apoptosis and caspase activation is potentiated by phospholipid scramblase-3. Apoptosis, 13, 845–856.
Nishizuka, Y. (1995). Protein kinase C and lipid signaling for sustained cellular responses. FASEB Journal, 9, 484–496.
O’Brian, C. A., Ward, N. E., Stewart, J. R., & Chu, F. (2001). Prospects for targeting protein kinase C isozymes in the therapy of drug-resistant cancer – an evolving story. Cancer and Metastasis Reviews, 20, 95–100.
Okhrimenko, H., Lu, W., Xiang, C., Ju, D., Blumberg, P. M., Gomel, R., et al. (2005). Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis. The Journal of Biological Chemistry, 280, 23643–23652.
Pal, S., Claffey, K. P., Dvorak, H. F., & Mukhopadhyay, D. (1997). The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. The Journal of Biological Chemistry, 272, 27509–27512.
Panaretakis, T., Hjortsberg, L., Tamm, K. P., Björklund, A. C., Joseph, B., & Grandér, D. (2008). Interferon alpha induces nucleusindependent apoptosis by activating extracellular signal-regulated kinase 1/2 and c-Jun NH2- terminal kinase downstream of phosphatidylinositol 3-kinase and mammalian target of rapamycin. Molecular Biology of the Cell, 19, 41–50.
Panaretakis, T., Laane, E., Pokrovskaja, K., Björklund, A. C., Moustakas, A., Zhivotovsky, B., et al. (2005). Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis. Molecular Biology of the Cell, 16, 3821–3831.
Peluso, J. J., Pappalardo, A., & Fernandez, G. (2001). Basic fibroblast growth factor maintains calcium homeostasis and granulosa cell viability by stimulating calcium efflux via a PKC delta-dependent pathway. Endocrinology, 142, 4203–4211.
Persaud, S. D., Hoang, V., Huang, J., & Basu, A. (2005). Involvement of proteolytic activation of PKCdelta in cisplatin-induced apoptosis in human small cell lung cancer H69 cells. International Journal of Oncology, 27, 149–154.
Podar, K., Raab, M. S., Chauhan, D., & Anderson, K. C. (2007). The therapeutic role of targeting protein kinase C in solid and hematologic malignancies. Expert Opinion on Investigational Drugs, 16, 1693–1707.
Pongracz, J., Clark, P., Neoptolemos, J. P., & Lord, J. M. (1995). Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids. International Journal of Cancer, 61, 35–39.
Prévostel, C., Martin, A., Alvaro, V., Jaffiol, C., & Joubert, D. (1997). Protein kinase C alpha and tumorigenesis of the endocrine gland. Hormone Research, 47, 140–144.
Ren, J., Datta, R., Shioya, H., Li, Y., Oki, E., Biedermann, V., et al. (2002). p73beta is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damage. The Journal of Biological Chemistry, 277, 33758–33765.
Renault-Mihara, F., Beuvon, F., Iturrioz, X., Canton, B., De Bouard, S., Léonard, N., et al. (2006). Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Molecular Biology of the Cell, 17, 5141–5152.
Reno, E. M., Haughian, J. M., Dimitrova, I. K., Jackson, T. A., Shroyer, K. R., & Bradford, A. P. (2008). Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors. Human Pathology, 39, 21–29.
Reyland, M. E., Anderson, S. M., Matassa, A. A., Barzen, K. A., & Quissell, D. O. (1999). Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells. The Journal of Biological Chemistry, 274, 19115–19123.
Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R. A., Ginsberg, M. H., Borisy, G., et al. (2003). Cell migration: Integrating signals from front to back. Science, 302, 1704–1709.
Rybin, V. O., Guo, J., Gertsberg, Z., Elouardighi, H., & Steinberg, S. F. (2007). Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation loop phosphorylation in cardiomyocytes. The Journal of Biological Chemistry, 282, 23631–23638.
Scheel-Toellner, D., Pilling, D., Akbar, A. N., Hardie, D., Lombardi, G., Salmon, M., et al. (1999). Inhibition of T cell apoptosis by IFNbeta rapidly reverses nuclear translocation of protein kinase C-delta. European Journal of Immunology, 29, 2603–2612.
Serova, M., Ghoul, A., Benhadji, K. A., Cvitkovic, E., Faivre, S., Calvo, F., et al. (2006). Preclinical and clinical development of novel agents that target the protein kinase C family. Seminars in Oncology, 33, 466–478.
Serova, M., Ghoul, A., Benhadji, K. A., Faivre, S., Le Tourneau, C., Cvitkovic, E., et al. (2008). Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells. Molecular Cancer Therapeutics, 7, 915–922.
Shin, S. Y., Kim, C. G., Ko, J., Min, D. S., Chang, J. S., Ohba, M., et al. (2004). Transcriptional and post-transcriptional regulation of the PKC delta gene by etoposide in L1210 murine leukemia cells: Implication of PKC delta autoregulation. Journal of Molecular Biology, 340, 681–693.
Song, K. S., Kim, J. S., Yun, E. J., Kim, Y. R., Seo, K. S., Park, J. H., et al. (2008). Rottlerin induces autophagy and apoptotic cell death through a PKC-delta independent pathway in HT1080 human fibrosarcoma cells: The protective use of autophagy in apoptosis. Autophagy, 4, 650–658.
Song, J. H., Song, D. K., Pyrzynska, B., Petruk, K. C., Van Meir, E. G., & Hao, C. (2003). TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways. Brain Pathology, 13, 539–553.
Song, J. S., Swann, P. G., Szallasi, Z., Blank, U., Blumberg, P. M., & Rivera, J. (1998). Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: Regulation of Src family kinase activity by protein kinase C-delta. Oncogene, 16, 3357–3368.
Steinberg, S. F. (2004). Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochemical Journal, 384, 449–459.
Steták, A., Lankenau, A., Vántus, T., Csermely, P., Ullrich, A., & Kéri, G. (2001). The antitumor somatostatin analogue TT-232 induces cell cycle arrest through PKCdelta and c-Src. Biochemical and Biophysical Research Communications, 285, 483–488.
Sun, X., Wu, F., Datta, R., Kharbanda, S., & Kufe, D. (2000). Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. The Journal of Biological Chemistry, 275, 7470–7473.
Takai, S., Matsushima-Nishiwaki, R., Tokuda, H., Yasuda, E., Toyoda, H., Kaneoka, Y., et al. (2007). Protein kinase C delta regulates the phosphorylation of heat shock protein 27 in human hepatocellular carcinoma. Life Sciences, 81, 585–591.
Tanaka, Y., Gavrielides, M. V., Mitsuuchi, Y., Fujii, T., & Kazanietz, M. G. (2003). Protein kinase C promotes apoptosis in LnCAP prostate cancer cells through activation of p38MAP kinase and inhibitin of the Akt survival pathway. The Journal of Biological Chemistry, 278, 33753–33762.
Tanaka, M., Terry, R. D., Mokhtari, G. K., Inagaki, K., Koyanagi, T., Kofidis, T., et al. (2004). Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts. Circulation, 110, II194–II199.
Toker, A. (1998). Signaling through protein kinase C. Frontiers in Bioscience, 3, D1134–D1147.
Varga, A., Czifra, G., Tallai, B., et al. (2004). Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas. European Urology, 46, 462–465.
Villar, J., Arenas, M. I., MacCarthy, C. M., Blánquez, M. J., Tirado, O. M., & Notario, V. (2007). PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism. Cancer Research, 67, 10859–10868.
Vucenik, I., Ramakrishna, G., Tantivejkul, K., Anderson, L. M., & Ramljak, D. (2005). Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation. Breast Cancer Research and Treatment, 91, 35–45.
Watanabe, T., Ono, Y., Taniyama, Y., Hazama, K., Igarashi, K., Ogita, K., et al. (1992). Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proceedings of the National Academy of Sciences of the United States of America, 89, 10159–10163.
Watters, D., Garrone, B., Coomer, J., Johnson, W. E., Brown, G., & Parsons, P. (1998). Stimulation of melanogenesis in a human melanoma cell line by bistratene A. Biochemical Pharmacology, 55, 1691–1699.
Wert, M. M., & Palfrey, H. C. (2000). Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: Rescue by bFGF involves protein kinase C delta. Biochemical Journal, 352 (Pt 1), 175–182.
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., et al. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673–682.
Woo, J. H., Lim, J. H., Kim, Y. H., Suh, S. I., Min, D. S., Chang, J. S., et al. (2004). Resveratrol inhibits phorbol myristate acetateinduced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene, 23, 1845–1853.
Woods Ignatoski, K. M., Livant, D. L., Markwart, S., Grewal, N. K., & Ethier, S. P. (2003). The role of phosphatidylinositol 3´-kinase and its downstream signals in erbB-2-mediated transformation. Molecular Cancer Research, 1, 551–560.
Xia, S., Forman, L. W., & Faller, D. V. (2007). Protein kinase C delta is required for survival of cells expressing activated p21RAS. The Journal of Biological Chemistry, 282, 13199–13210.
Yokoyama, G., Fujii, T., Tayama, K., Yamana, H., Kuwano, M., & Shirouzu, K. (2005). PKCdelta and MAPK mediate G(1) arrest induced by PMA in SKBR-3 breast cancer cells. Biochemical and Biophysical Research Communications, 327, 720–726.
Yuan, Z. M., Utsugisawa, T., Ishiko, T., Nakada, S., Huang, Y., Kharbanda, S., et al. (1998). Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation. Oncogene, 16, 1643–1648.
Yuspa, S. H. (1998). The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis. Journal of Dermatological Science, 17, 1–7.
Zeng, Z. Z., Jia, Y., Hahn, N. J., Markwart, S. M., Rockwood, K. F., & Livant, D. L. (2006). Role of focal adhesion kinase and phosphatidylinositol 3´-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Research, 66, 8091–8099.
Zrachia, A., Dobroslav, M., Blass, M., Kazimirsky, G., Kronfeld, I., Blumberg, P. M., et al. (2002). Infection of glioma cells with Sindbis virus induces selective activation and tyrosine phosphorylation of protein kinase C delta. Implications for Sindbis virus-induced apoptosis. The Journal of Biological Chemistry, 277, 23693–23701.
Cai, J., Donaldson, A., Yang, M., German, M. S., Enikolopov, G., Iacovitti, L. (2009) The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson’s disease model. Stem Cells, 27, 220-229.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Brodie, C., Lomonaco, S.L. (2010). PKCδ as a Target for Chemotherapeutic Drugs. In: Kazanietz, M. (eds) Protein Kinase C in Cancer Signaling and Therapy. Current Cancer Research. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-543-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-60761-543-9_22
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-542-2
Online ISBN: 978-1-60761-543-9
eBook Packages: MedicineMedicine (R0)